ID
45931
Descripción
Principal Investigator: Raymond J. Cho, MD, PhD, University of California, San Francisco, CA, USA MeSH: Xeroderma Pigmentosum, Complementation Group C,Carcinoma, Squamous Cell,Skin Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000830 Base mutations occur at higher frequencies within heterochromatin and late-replicating DNA. In this study, we show that regional differences in mutation frequency are absent in portions of the genome that are not transcribed within cutaneous squamous cell carcinomas (cSCCs) with an XPC-\- genetic background. The XPC-\- genetic background predicates a loss of global genome nucleotide excision repair (GG-NER), thus our data shows that regional differences in mutation frequency are a result of differential access of DNA repair protein. Unexpectedly, we also note that greater transcription reduces mutations on both strands of genes in heterochromatin, and only to those levels observed in euchromatin, in a XPC-dependent fashion. Therefore, transcription likely reduces mutation prevalence by increasing access to DNA repair proteins. This tripartite relationship between DNA repair, transcription, and chromatin state shows a new cancer risk factor in human populations.
Link
Palabras clave
Versiones (1)
- 9/3/24 9/3/24 - Madita Rudolph
Titular de derechos de autor
Raymond J. Cho, MD, PhD, University of California, San Francisco, CA, USA
Subido en
9 de marzo de 2024
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000830 XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study
Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, gender, and germline repair genotype of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Sample ID, body site, analyte type, tumor status, histological type, primary or metastatic tumor, primary tumor location, and sequencing center of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
Similar models
Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, gender, and germline repair genotype of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Sample ID, body site, analyte type, tumor status, histological type, primary or metastatic tumor, primary tumor location, and sequencing center of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
C0441833 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])